Fibronectin pathway may drive Marfan aortic damage, opening new drug targets

Fibronectin pathway may drive Marfan aortic damage, opening new drug targets. A new study published in Nature Communications identifies a molecular signaling pathway that contributes to the development of life-threatening aortic aneurysms and dissections in Marfan syndrome, a genetic disorder affecting connective tissue.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: A new study published in Nature Communications identifies a molecular signaling pathway that contributes to the development of life-threatening aortic aneurysms and dissections in Marfan syndrome, a genetic disorder affecting connective tissue. The findings provide new insight into how structural alterations in the aortic wall lead to disease progression and point to potential therapeutic targets.

• Ponto de atenção: fibronectin.
• Ponto de atenção: pathway.
• Ponto de atenção: drive.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.